Berberine chloride hydrate

• CAT Number: I001579
• CAS Number: 141433-60-5
• Molecular Formula: C20H18ClNO4
• Molecular Weight: 371.81
• Purity: ≥95%
• Target: Anticancer agent
• Solubility: DMSO: ≥ 3.9 mg/mL, DMSO: ＜ 9.2 mg/mL, H2O: ＜ 4 mg/mL
• Storage: 3 years -20C powder
• IUPAC Name: 16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene;chloride;hydrate
• InChI: InChI=1S/C20H18NO4.ClH.H2O/c1-22-17-4-3-12-7-16-14-9-19-18(24-11-25-19)8-13(14)5-6-21(16)10-15(12)20(17)23-2;;/h3-4,7-10H,5-6,11H2,1-2H3;1H;1H2/q+1;;/p-1
• InChIKey: BPNJXFPOPCFZOC-UHFFFAOYSA-M
• SMILES: COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC.O.[Cl-]

Berberine Chloride Hydrate(CAT: I001579) is an isoquinoline alkaloid widely studied for its diverse pharmacological activities, including antimicrobial, anti-inflammatory, antidiabetic, and anticancer effects. It acts by interacting with multiple molecular targets, such as AMPK activation, inhibition of DNA and RNA synthesis in pathogens, and modulation of oxidative stress and lipid metabolism. Berberine chloride hydrate is commonly used in research on metabolic disorders, cardiovascular diseases, and microbial infections. Its broad biological activity and high stability make it a valuable compound for exploring therapeutic mechanisms and developing novel treatments for various health conditions.